Reduction of immunosuppressive agents after living related donor liver transplantation.
Tanaka
M
M
First Department of Surgery, Nagoya City University Medical School, Japan.
Otobe
Y
Y
Hashimoto
T
T
Shimizu
Y
Y
Suzuki
T
T
Nakamura
Y
Y
Itoh
K
K
Satoh
M
M
Ueda
N
N
Manabe
T
T
D000017:ABO Blood-Group System; D001379:Azathioprine / Q000627:therapeutic use; D001788:Blood Grouping and Crossmatching; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005220:Fathers; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D009035:Mothers; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D014019:Tissue Donors
D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D016559:Tacrolimus